This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Self-Management » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Medication Nonadherence Prevalent in Diabetics is Associated with Adverse Outcom

Posted: Thursday, December 07, 2006

Medication nonadherence was significantly associated with increased risks for all-cause hospitalization and for all-cause mortality.

Januvia Combo Soon to Be Available - JANUMET

Posted: Thursday, December 07, 2006

Within weeks of Januvia being approved, Merck & Co. is ready to come out with a combination product of Januvia and metformin.

Results Announced from ADOPT (A Diabetes Outcome Progression Trial)

Posted: Thursday, December 07, 2006

Landmark Study compares effectiveness of single therapy with rosiglitazone, sulfonylurea and metformin in a head to head comparison with 4360 newly diagnosed Type 2’s.

Exubera Slow to Catch On

Posted: Thursday, December 07, 2006

Jury is still out on Exubera. Diabetics are holding their breath, and that may not be good news for the Pfizer, the world's biggest drugmaker. It's been nearly a year since the FDA approved Exubera, the first inhalable form of insulin for diabetics. Some analysts hail the device as a potential blockbuster, but Exubera doesn't appear to have caught on.

Sitagliptin Role As Monotherapy, Adjunct

Posted: Thursday, November 30, 2006

The newly licensed glucose-lowering agent sitagliptin phosphate (Januvia) appears safe and somewhat effective. It could become a replacement for sulfonylurea, due to its ability to control blood sugars without weight gain and hypoglycemia.

Diabetes and Metabolic Syndrome Treated with Malaria Drug

Posted: Wednesday, November 22, 2006

Studies of a rare genetic condition that increases cancer risk have unveiled a potential treatment for metabolic syndrome, and diabetes disorders that afflicts as many as one in every four American adults and puts them at sharply increased risk cardiovascular disease, heart attacks and strokes.

Rimonabant (Accomplia) to Treat Obesity and Improve Glycemic Control Approved in Mexico

Posted: Wednesday, November 22, 2006

Accomplia is now approved in Europe and Mexico, US next?

WelChol Improves Glycemic Control and Cholesterol in Uncontrolled Type 2’s

Posted: Wednesday, November 22, 2006

This is the first study ever to evaluate WelChol in combination with insulin, and it demonstrated A1C reductions of 0.5%

Januvia™ Works For for First and Second-Line Management of Type 2 Diabetes

Posted: Thursday, November 16, 2006

The FDA has approved sitagliptin for use with diet and exercise or in combination with metformin or the TZDs to improve glycemic control in adult patients with type 2 diabetes.

More Treatment Options for Diabetes Means Few Excuses for High Blood Sugar

Posted: Thursday, November 16, 2006

A generation ago, there was just one kind of pill that could help people with diabetes keep their blood sugar levels down. But today, so many new options are available that it's almost dizzying. Advertisements for the new medicines seem to be everywhere, and more new medicines are on the way.